beta-hydroxyisovaleric acid has been researched along with Debility in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bruni, A; De Santis, A; Di Cola, S; Lattanzi, B; Merli, M; Molfino, A; Muscaritoli, M | 1 |
| Cruz-Jentoft, AJ | 1 |
| Duque, G; Oktaviana, J; Vogrin, S; Zanker, J | 1 |
2 review(s) available for beta-hydroxyisovaleric acid and Debility
| Article | Year |
|---|---|
Beta-Hydroxy-Beta-Methyl Butyrate (HMB): From Experimental Data to Clinical Evidence in Sarcopenia.
Topics: Aged; Aged, 80 and over; Aging; Apoptosis; Cell Survival; Dietary Supplements; Frailty; Humans; Leucine; Middle Aged; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Sarcopenia; Valerates | 2018 |
The Effect of β-hydroxy-β-methylbutyrate (HMB) on Sarcopenia and Functional Frailty in Older Persons: A Systematic Review.
Topics: Aged; Aged, 80 and over; Body Composition; Dietary Supplements; Female; Frailty; Hand Strength; Humans; Male; Muscle, Skeletal; Randomized Controlled Trials as Topic; Sarcopenia; Valerates | 2019 |
1 trial(s) available for beta-hydroxyisovaleric acid and Debility
| Article | Year |
|---|---|
The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study.
Topics: Anthropometry; Dietary Supplements; Electric Impedance; Exercise; Female; Frailty; Humans; Liver Cirrhosis; Male; Middle Aged; Muscle Strength; Muscle, Skeletal; Pilot Projects; Sarcopenia; Single-Blind Method; Treatment Outcome; Valerates | 2021 |